RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Cash from operations

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.5B
P/E ratio
-3.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2025-1,250+8.08%
Mar 31, 2024-1,157-3.94%
Mar 31, 2023-1,204-20.35%
Mar 31, 2022-1,512-14.57%
Mar 31, 2021-1,770-0.82%
Mar 31, 2020-1,784+22.43%
Mar 31, 2019-1,458-8.41%
Mar 31, 2018-1,591+49.07%
Mar 31, 2017-1,068+17.48%
Mar 31, 2016-909+103.20%
Mar 31, 2015-447

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)